A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi ...
Announced increased focus on type 1 diabetes and in vivo CAR T programsRegulatory interactions increase confidence in moving forward with GMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback